Cameco has pulled back sharply in recent months after a strong multi year run. This puts a spotlight on whether today's share price still lines up with the cash the business is expected to generate. With investors weighing both uranium market headlines and new capital raising plans, the key issue is how those factors flow through to future cash flows per share.
The issue now is whether Cameco's recent share price, after that multi year gain and the new funding program, is justified by the cash flows implied by a Discounted Cash Flow (DCF) view.
If you are weighing Cameco against other opportunities tied to nuclear infrastructure and fuel supply chains, it can help to compare it with a wider set of 16 nuclear energy infrastructure stocks.
The Discounted Cash Flow (DCF) model here focuses on the cash Cameco can return to shareholders over time. Latest twelve month free cash flow sits at about CA$464.4m, and analysts are modelling CA$2.4b of annual free cash flow by 2030, which implies a growing cash generation profile rather than a one off spike. That growth path, combined with a two stage framework that tapers longer term expectations, underpins an estimated intrinsic value that the model suggests is meaningfully above the current CA$94.40 share price.
The renewed US$1b at the market equity program helps explain why the market might hesitate, since any fresh share issuance would spread those future CA$ billions over a larger shareholder base. Despite that potential dilution, the DCF still points to cash flows that support a higher value than what is currently implied in the trading price. This is what the detailed model output helps you compare against. Find out what Cameco could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives for Cameco pick up where the DCF puzzle leaves off. They spell out which paths for Cameco's growth, margins and earnings would need to play out for the shares to end up worth materially more or less than where they trade today on the Community page. Each scenario links a fair value to a particular story about the uranium producer's potential catalysts and downside risks, so you can track over time which version of events appears to be taking shape.
One of the top narratives on Cameco: 44% undervalued
This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.
"The current valuation implies the share price does not fully reflect this narrative’s positive view that Cameco’s contracted volumes, pricing terms, and exposure to AP1000 new build programs support stronger long-run earnings power…"
Discover why this Narrative puts Cameco at 44% undervalued.
Cameco's cash flow outlook and funding plans are only part of the picture. The people directing capital, and how they are rewarded, can tilt long term outcomes in subtle but powerful ways. See who runs Cameco and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com